WASHINGTON, Oct. 6, 2011 — Legal publisher Main Justice will host a panel discussion on Tuesday, Oct. 18 from 11:30 a.m. to 2 p.m. in the Rayburn House Office Building.
The government’s increasingly creative theories of health care fraud and abuse enforcement are raising questions about due process and the limits of criminal liability for corporations and executives. Our panel of industry lawyers and experts explores what it means when prosecutors become de facto regulators of health care and pharmaceutical companies.
The deficit reduction supercommittee is considering ramping up the already aggressive efforts to reap billions of dollars in fines from major health care players as a new way to close the $1.5 trillion budget gap. At the same time, recent articles in The Wall Street Journal, The New York Times and The Washington Post reflect growing concerns about prosecution tactics. No industry is more impacted by these controversial tactics than health care.
Join us as we explain such hot-button topics as debarment, individual prosecutions, off-label marketing and the False Claims Act. We will present real-life case studies on prosecutions of companies from Allergan, maker of Botox, to Tenet Healthcare.
- Jeff Bucholtz, partner at King & Spalding LLP and former Acting Assistant Attorney General in the Department of Justice
- Vicki Girard, professor at Georgetown Law Center
- Joan McPhee, partner at Ropes & Gray LLP and former U.S. Attorney in the Southern District of New York
- Peter Urbanowicz, managing director at Alvarez & Marsal and former deputy general counsel of Health and Human Services and, more recently, executive vice president and general counsel of Tenet Healthcare
Tuesday, October 18, 2011
11:30 a.m. to 2 p.m.
2168 Rayburn House Office Building
Washington, D.C. 20515
Mary Jacoby, Editor-in-Chief of Main Justice, (202) 654-7049 or firstname.lastname@example.org
Brenn Huckstep, Events Manager for Main Justice, (202) 654-7074 or email@example.com